Editorial Office, Journal of Health Policy and Management, United Kingdom

Publications

• Short communication   
  Assessment of hepcidin levels in COVID-19 patients entering the intensive care unit
  Author(s): James Brown*
  
  The COVID-19 coronavirus disease's clinical spectrum ranges from a minor illness to a major illness. Multi-organ failure brought on by the so-called "cytokine storm," respiratory failure, septic shock, and/or septic shock can be seen in patients with severe diseases. The main way that inflammatory cytokines affect iron metabolism is through increasing the production of the rarely measured hormone peptide hepcidin. High hepcidin levels have been associated with the severity of COVID-19. In this study, a sample of COVID-19 patients who had been admitted to the Intensive Care Unit (ICU) at the Policlinico Tor Vergata in Rome, Italy, had their levels of hepcidin retrospectively examined. 38 people were included in the trial between November 2020 and May 2021. Based on the clinical outcome, patients were split into two groups: survivors and non-survivors. A number of common l.. Read More»
  DOI: 10.37532/pulhpm.23.6 (1).10-11

  • Abstract
  • Full-Text
  • PDF